… Patient perspectives provide context for research advances discussed at the IASLC 2020 North America … issues, clinical trial participation and design, and research endpoints that are meaningful to the lung cancer community.  The conference will provide research updates in the forms of data presentations given by …

… Chris Martin CMartin@DavidJamesGroup.com | 630-670-2745 Research Presented at the International Association for the … of 20% major pathologic response rate, according to research presented today at the International Association for … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …

… STK11 ,  KEAP1  or  KRAS  mutational status, according to research from the POSEIDON trial presented at the IASLC World … with  STK11  and/or  KEAP1 . Based on these findings, researchers theorized that the triplet regimen tremelimumab, … ,  STK11  and  KEAP1  mutational status. Dr. Peters and researchers at study locations randomized   1013 patients …

… declined 43% during the COVID-19 pandemic, according to research presented today at the IASLC 2021 World Conference on … suspension of trials (60%), institutional closures (39%), research staff availability (48%), and protocol compliance … (14%),” Dr. Smeltzer said. To respond to these barriers, researchers used several strategies, including: modified …

… on Lung Cancer highlights the best in lung cancer research. Like the previous two meetings, this conference will … moderated by an IASLC member and include an IASLC Patient Research Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer. Zoom …

… community including physicians, nurses, other clinicians, researchers and scientists as well as patients, survivors and … include interactive educational sessions, late-breaking research, live chats with industry and e-poster presenters, … By hosting global conferences, funding cutting-edge research and educating the health care community and the …

… platinum and pemetrexed chemotherapy alone, according to research presented today the International Association for the … (platinum and pemetrexed) or chemotherapy alone. The researchers followed patients for a median 22.4 months. … emerged after 42 months, Lim reported. Moreover, the research unveiled significant disparities in progression-free …

… Chris Martin CMartin@DavidJamesGroup.com | 630-670-2745 Research Presented at International Association for the Study … from the ADAURA clinical trial advanced previous research that demonstrated improved disease-fee survival (DFS) … other thoracic malignancies, attracting more nearly 7,500 researchers, physicians and specialists from more than 100 …

… Growth Represents the Quality of Research and the Speed to Publication for the IASLC’s Official … a multidisciplinary approach, the JTO includes original research, review articles and opinion pieces. The audience … and quick handling of manuscripts is attractive to many researchers as they consider where to submit.” The JTO …

… on Lung Cancer highlights the best in lung cancer research. Like the previous two meetings, this conference will … moderated by an IASLC member and include an IASLC Patient Research Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer. Zoom …

… Health Organization classification system, according to research unveiled at the International Association for the … resected adenocarcinomas measuring up to 3 cm (n=70), the research evaluated the potential of a modified classification … concerns about inconsistent assessments. Importantly, the research revealed that cases scored with "no-invasion" …

… lung cancer patients’ voices through transformative research. Our final goal with research is to have compassionate and supportive treatment for … other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …